Innovent Biologics Inc (6IB) — Cash Flow Quality Index
Innovent Biologics Inc (6IB) has a Cash Flow Quality Index of 12.29x as of December 2025. Operating cash flow of €10.00 Billion exceeds net income of €813.57 Million, indicating high earnings quality where cash backs reported profits. Also explore Innovent Biologics Inc (6IB) total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Innovent Biologics Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Innovent Biologics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 6IB goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Innovent Biologics Inc (2025–2025)
Year-by-year earnings quality comparison for Innovent Biologics Inc. For live market cap and the full company financial profile, see market cap of Innovent Biologics Inc.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 12.29x | €10.00 Billion | €813.57 Million | — |